Electrochemical aptasensor for human osteopontin detection using a DNA aptamer selected by SELEX
Open Access
- 1 September 2017
- journal article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 987, 25-37
Abstract
No abstract availableKeywords
Funding Information
- BioTecNorte (NORTE-01-0145-FEDER-000004)
- Associate Laboratory LSRE-LCM
- FEDER - Fundo Europeu de Desenvolvimento Regional
- COMPETE2020
- Programa Operacional Competitividade e Internacionalização (POCI)
- FCT - Fundação para a Ciência e a Tecnologia
This publication has 63 references indexed in Scilit:
- Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside AntibioticsJournal of Analytical Methods in Chemistry, 2012
- Pre- and post-translational regulation of osteopontin in cancerJournal of Cell Communication and Signaling, 2011
- Osteopontin is a marker for cancer aggressiveness and patient survivalBritish Journal of Cancer, 2010
- Aptamer-Based Electrochemical Biosensor for Interferon Gamma DetectionAnalytical Chemistry, 2010
- Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patientsBMC Cancer, 2010
- Clinical Significance of the Upregulated Osteopontin mRNA Expression in Human Colorectal CancerJournal of Gastrointestinal Surgery, 2010
- RNA Aptamer Blockade of Osteopontin Inhibits Growth and Metastasis of MDA-MB231 Breast Cancer CellsMolecular Therapy, 2009
- Osteopontin‐c is a selective marker of breast cancerInternational Journal of Cancer, 2007
- Osteopontin overexpression in breast cancer: Knowledge gained and possible implications for clinical managementJournal of Cellular Biochemistry, 2007
- Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast CancerClinical Cancer Research, 2006